Autosomal Dominant Polycystic Kidney Disease (ADPKD) Not Yet Recruiting Phase 4 Trials for Tolvaptan (DB06212)

Also known as: Autosomal Dominant Polycystic Kidney Disease / Polycystic Kidney Disease, Autosomal Dominant / ADPKD (Autosomal Dominant Polycystic Kidney Disease) / ADPKD / Polycystic Kidney, Autosomal Dominant / Autosomal Dominant Polycystic Kidney Disease (ADPKD / Autosomal Dominant Polycystic Kidney / Kidney, Polycystic, Autosomal Dominant / Autosomal Dominant Polycystic Kidney Disease (ADPKD) / Congenital cystic kidney disease NOS / Congenital cystic kidney disease

IndicationStatusPhase
DBCOND0050861 (Autosomal Dominant Polycystic Kidney Disease (ADPKD))Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03596957Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney DiseaseTreatment